MILLMIRJA Trademark

Trademark Overview


On Thursday, November 7, 2024, a trademark application was filed for MILLMIRJA with the United States Patent and Trademark Office. The USPTO has given the MILLMIRJA trademark a serial number of 98842421. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 23, 2025. This trademark is owned by Bristol-Myers Squibb Company. The MILLMIRJA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for human use.
millmirja

General Information


Serial Number98842421
Word MarkMILLMIRJA
Filing DateThursday, November 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events


Event DateEvent Description
Thursday, November 7, 2024NEW APPLICATION ENTERED
Sunday, May 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 6, 2025ASSIGNED TO EXAMINER
Friday, May 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 23, 2025NON-FINAL ACTION WRITTEN
Friday, May 23, 2025NON-FINAL ACTION E-MAILED